|
|||||
|
|
Structure‐Based Design of Selective Noncovalent CDK12 Inhibitors |
|
| Authors: | Dr. Jeffrey W. Johannes Christopher R. Denz Nancy Su Allan Wu Anna C. Impastato Dr. Scott Mlynarski Jeffrey G. Varnes D. Bryan Prince Dr. Justin Cidado Ning Gao Dr. Malcolm Haddrick Natalie H. Jones Shaobin Li Xiuwei Li Yang Liu Dr. Toan B. Nguyen Dr. Nichole O'Connell Dr. Emma Rivers Dr. Daniel W. Robbins Ronald Tomlinson Dr. Tieguang Yao Xiahui Zhu Dr. Andrew D. Ferguson Dr. Michelle L. Lamb Dr. John I. Manchester Dr. Sylvie Guichard |
| Affiliation: | 1. Oncology, IMED Biotech Unit, AstraZeneca, Boston, MA, USA;2. Discovery Sciences, IMED Biotech Unit, AstraZeneca, Boston, MA, USA;3. Discovery Sciences, IMED Biotech Unit, AstraZeneca Pharmaceuticals LP, Macclesfield, UK;4. Pharmaron Beijing Co. Ltd., Beijing, P.R. China;5. Discovery Sciences, IMED Biotech Unit, AstraZeneca Pharmaceuticals LP, Cambridge, UK |
| Abstract: | |
| Keywords: | |